1. 1356. Improvement in Quality of Life for Adults With Acute Bacterial Skin and Skin Structure Infections Following Treatment With Omadacycline or Linezolid. (26th November 2018) Authors: Tzanis, Evan; Chitra, Surya; Curran, Marla; McGovern, Paul; Hinahara, Jordan; Goss, Thomas Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic. (26th November 2018) Authors: Opal, Steven; File, Thomas M; Van Der Poll, Tom; McGovern, Paul; Tzanis, Evan; Chitra, Surya Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1492. Targeted Substitution of Omadacycline in Place of Standard of Care for CABP Treatment is Associated with a Risk Reduction of Clostridioides difficile Infection and Financial Cost Savings in the Acute Care Setting. (31st December 2020) Authors: Rodriguez, Mauricio; Chitra, Surya; Wright, Kelly; Lodise, Thomas Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1687. Omadacycline in Female Adults With Acute Pyelonephritis: Results from a Randomized, Double-Blind, Adaptive Phase 2 Study. (31st December 2020) Authors: Overcash, J Scott; Tzanis, Evan; Manley, Amy; Kirsch, Courtney; Serio, Alisa W; White, Tiffany; Wright, Kelly; Chitra, Surya; Eckburg, Paul B Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1688. Omadacycline in Female Adults With Cystitis: Results From a Randomized, Double-Blinded, Adaptive Phase 2 Study. (31st December 2020) Authors: Overcash, J Scott; Tzanis, Evan; Manley, Amy; Sirbu, Alissa; Serio, Alisa W; White, Tiffany; Wright, Kelly; Chitra, Surya; Eckburg, Paul B Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 767. Incidence of C. difficile infection (CDI) Cases by CDI-Standardized Infection Ratio (SIR) Among Centers for Medicare and Medicaid Services (CMS)-Participating Short-Term Acute Care Hospitals (ACH) Post Implementation of the Hospital-Acquired Condition Reduction Program (HAC-RP). (4th December 2021) Authors: Rodriguez, Mauricio; Chitra, Surya; Lavallee, Paige; Mallow, Peter J; Lodise, Thomas; Lodise, Thomas Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Safety of Omadacycline in Chronic Kidney Disease (CKD) Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): A Subgroup Analysis from the OASIS Tria. (4th October 2017) Authors: File, Thomas M; Cure-Bolt, Nancy; Chitra, Surya; Tzanis, Evan; McGovern, Paul Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and Safety of Omadacycline in Intravenous Drug Using (IVDU) and Hepatitis C-Positive (HCV+) Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): A Subgroup Analysis from the OASIS Trial. (4th October 2017) Authors: Ohl, Christopher; Cure-Bolt, Nancy; Chitra, Surya; Tzanis, Evan; McGovern, Paul Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and Safety of Omadacycline in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and High Body Mass Index or Type 2 Diabetes: A Subgroup Analysis from the OASIS Tria. (4th October 2017) Authors: Wilcox, Mark; Cure-Bolt, Nancy; Chitra, Surya; Tzanis, Evan; McGovern, Paul Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial. (8th September 2021) Authors: Chitra, Surya; Hinahara, Jordan; Goss, Thomas F; Gunter, Kyle; LaPensee, Kenneth Journal: Open forum infectious diseases Issue: Volume 8:Number 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗